Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patent ductus arteriosus: pathophysiology and management.

E R Hermes-DeSantis1, R I Clyman

  • 1Drug Information Service, Robert Wood Johnson University Hospital, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Jersey, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|April 21, 2006
PubMed
Summary

Patent ductus arteriosus (PDA) in preterm infants presents treatment challenges. This review explores evidence and experience on optimal timing for indomethacin intervention to manage PDA and associated comorbidities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.

Journal of perinatology : official journal of the California Perinatal Association·2014
Same author

Prostanoid receptors: ontogeny and implications in vascular physiology.

American journal of physiology. Regulatory, integrative and comparative physiology·2001
Same author

Combined prostaglandin and nitric oxide inhibition produces anatomic remodeling and closure of the ductus arteriosus in the premature newborn baboon.

Pediatric research·2001
Same author

Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling.

American journal of physiology. Regulatory, integrative and comparative physiology·2001
Same author

Characterization of PGE2 receptors in fetal and newborn ductus arteriosus in the pig.

Seminars in perinatology·2001
Same author

Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus.

American journal of physiology. Heart and circulatory physiology·2001

Area of Science:

  • Neonatalogy
  • Pediatric Cardiology

Background:

  • Patent ductus arteriosus (PDA) is common in preterm newborns (<28 weeks gestation).
  • PDA can lead to increased pulmonary blood flow and affect organ perfusion.
  • Associated comorbidities include necrotizing enterocolitis, intracranial hemorrhage, and bronchopulmonary dysplasia, though causality is debated.

Purpose of the Study:

  • To review evidence and clinical experience regarding treatment strategies for PDA in preterm infants.
  • To discuss the optimal timing for intervention, contrasting early prophylaxis with treatment upon symptom manifestation.
  • To explore the comparative physiology of PDA closure in term versus preterm neonates.

Main Methods:

  • Review of existing evidence and clinical experience.
  • Discussion of prostaglandin inhibitor efficacy, specifically indomethacin.

Related Experiment Videos

  • Analysis of physiological differences between term and preterm newborns concerning PDA closure.

    • Main Results:

    • Indomethacin is an effective treatment for PDA.
    • The optimal timing for intervention remains a significant clinical challenge.
    • Understanding physiological barriers to PDA constriction in preterm infants is crucial.

    Conclusions:

    • Optimal timing for PDA intervention in preterm infants requires careful consideration of evidence and experience.
    • Further research may clarify the causal role of PDA in neonatal comorbidities.
    • Addressing PDA effectively is critical for improving outcomes in extremely preterm newborns.